Ribe Anette Riisgaard, Laurberg Tinne, Laursen Thomas Munk, Charles Morten, Vedsted Peter, Vestergaard Mogens
Research Unit for General Practice, Department of Public Health, Aarhus University, Bartholins Allé 2, 8000 Aarhus C, Denmark.
Section for General Medical Practice, Department of Public Health, Aarhus University, Bartholins Allé 2, 8000 Aarhus C, Denmark.
PLoS One. 2016 Jul 27;11(7):e0158013. doi: 10.1371/journal.pone.0158013. eCollection 2016.
Breast cancer is the leading cause of cancer death in women worldwide. Nevertheless, it is unknown whether higher mortality after breast cancer contributes to the life-expectancy gap of 15 years in women with severe mental illness (SMI).
We estimated all-cause mortality rate ratios (MRRs) of women with SMI, women with breast cancer and women with both disorders compared to women with neither disorder using data from nationwide registers in Denmark for 1980-2012.
The cohort included 2.7 million women, hereof 31,421 women with SMI (12,852 deaths), 104,342 with breast cancer (52,732 deaths), and 1,106 with SMI and breast cancer (656 deaths). Compared to women with neither disorder, the mortality was 118% higher for women with SMI (MRR: 2.18, 95% confidence interval (CI): 2.14-2.22), 144% higher for women with breast cancer (MRR: 2.44, 95% CI: 2.42-2.47) and 327% higher for women with SMI and breast cancer (MRR: 4.27, 95% CI: 3.98-4.57). Among women with both disorders, 15% of deaths could be attributed to interaction. In a sub-cohort of women with breast cancer, the ten-year all-cause-mortality was 59% higher after taking tumor stage into account (MRR: 1.59, 95% CI: 1.47-1.72) for women with versus without SMI.
The mortality among women with SMI and breast cancer was markedly increased. More information is needed to determine which factors might explain this excess mortality, such as differences between women with and without SMI in access to diagnostics, provision of care for breast cancer or physical comorbidity, health-seeking-behavior, and adherence to treatment.
乳腺癌是全球女性癌症死亡的主要原因。然而,乳腺癌后较高的死亡率是否导致了重度精神疾病(SMI)女性15年的预期寿命差距尚不清楚。
我们使用丹麦全国登记处1980 - 2012年的数据,估计了与无这两种疾病的女性相比,患有SMI的女性、患有乳腺癌的女性以及同时患有这两种疾病的女性的全因死亡率比值(MRR)。
该队列包括270万女性,其中31421名患有SMI的女性(12852人死亡),104342名患有乳腺癌的女性(52732人死亡),以及1106名同时患有SMI和乳腺癌的女性(656人死亡)。与无这两种疾病的女性相比,患有SMI的女性死亡率高118%(MRR:2.18,95%置信区间(CI):2.14 - 2.22),患有乳腺癌的女性死亡率高144%(MRR:2.44,95%CI:2.42 - 2.47),同时患有SMI和乳腺癌的女性死亡率高327%(MRR:4.27,95%CI:3.98 - 4.57)。在同时患有这两种疾病的女性中,15%的死亡可归因于相互作用。在患有乳腺癌的女性亚队列中,考虑肿瘤分期后,患有SMI的女性与未患有SMI的女性相比,十年全因死亡率高59%(MRR:1.59,95%CI:1.47 - 1.72)。
患有SMI和乳腺癌的女性死亡率显著增加。需要更多信息来确定哪些因素可能解释这种过高的死亡率,例如患有和未患有SMI的女性在获得诊断、乳腺癌护理或身体合并症的治疗、就医行为以及治疗依从性方面的差异。